Arakawa H - Search Results

1

Directed evolution of an angiopoietin-2 ligand trap by somatic hypermutation and cell surface display.

Brindle NP, Sale JE, Arakawa H, Buerstedde JM, Nuamchit T, Sharma S, Steele KH. Brindle NP, et al. Among authors: arakawa h. J Biol Chem. 2013 Nov 15;288(46):33205-12. doi: 10.1074/jbc.M113.510578. Epub 2013 Oct 8. J Biol Chem. 2013. PMID: 24106271 Free PMC article.

2

Activation-induced cytidine deaminase-mediated hypermutation in the DT40 cell line.

Arakawa H, Buerstedde JM. Arakawa H, et al. Philos Trans R Soc Lond B Biol Sci. 2009 Mar 12;364(1517):639-44. doi: 10.1098/rstb.2008.0202. Philos Trans R Soc Lond B Biol Sci. 2009. PMID: 19008193 Free PMC article. Review.

3

Targeting of somatic hypermutation by immunoglobulin enhancer and enhancer-like sequences.

Buerstedde JM, Alinikula J, Arakawa H, McDonald JJ, Schatz DG. Buerstedde JM, et al. Among authors: arakawa h. PLoS Biol. 2014 Apr 1;12(4):e1001831. doi: 10.1371/journal.pbio.1001831. eCollection 2014 Apr. PLoS Biol. 2014. PMID: 24691034 Free PMC article.

4

RDM1, a novel RNA recognition motif (RRM)-containing protein involved in the cell response to cisplatin in vertebrates.

Hamimes S, Arakawa H, Stasiak AZ, Kierzek AM, Hirano S, Yang YG, Takata M, Stasiak A, Buerstedde JM, Van Dyck E. Hamimes S, et al. Among authors: arakawa h. J Biol Chem. 2005 Mar 11;280(10):9225-35. doi: 10.1074/jbc.M412874200. Epub 2004 Dec 14. J Biol Chem. 2005. PMID: 15611051 Free article.

5

Immunoglobulin gene conversion or hypermutation: that's the question.

Buerstedde JM, Arakawa H. Buerstedde JM, et al. Among authors: arakawa h. Subcell Biochem. 2006;40:11-24. doi: 10.1007/978-1-4020-4896-8_2. Subcell Biochem. 2006. PMID: 17623897 Review.

6

Protein evolution by hypermutation and selection in the B cell line DT40.

Arakawa H, Kudo H, Batrak V, Caldwell RB, Rieger MA, Ellwart JW, Buerstedde JM. Arakawa H, et al. Nucleic Acids Res. 2008 Jan;36(1):e1. doi: 10.1093/nar/gkm616. Epub 2007 Dec 11. Nucleic Acids Res. 2008. PMID: 18073192 Free PMC article.

7

Identification of core DNA elements that target somatic hypermutation.

Kohler KM, McDonald JJ, Duke JL, Arakawa H, Tan S, Kleinstein SH, Buerstedde JM, Schatz DG. Kohler KM, et al. Among authors: arakawa h. J Immunol. 2012 Dec 1;189(11):5314-26. doi: 10.4049/jimmunol.1202082. Epub 2012 Oct 19. J Immunol. 2012. PMID: 23087403 Free PMC article.

8

Immunoglobulin gene conversion: insights from bursal B cells and the DT40 cell line.

Arakawa H, Buerstedde JM. Arakawa H, et al. Dev Dyn. 2004 Mar;229(3):458-64. doi: 10.1002/dvdy.10495. Dev Dyn. 2004. PMID: 14991701 Free article. Review.

9

Activation-induced cytidine deaminase initiates immunoglobulin gene conversion and hypermutation by a common intermediate.

Arakawa H, Saribasak H, Buerstedde JM. Arakawa H, et al. PLoS Biol. 2004 Jul;2(7):E179. doi: 10.1371/journal.pbio.0020179. Epub 2004 Jul 13. PLoS Biol. 2004. PMID: 15252444 Free PMC article.

10

Dt40 gene disruptions: a how-to for the design and the construction of targeting vectors.

Arakawa H, Buerstedde JM. Arakawa H, et al. Subcell Biochem. 2006;40:1-9. doi: 10.1007/978-1-4020-4896-8_1. Subcell Biochem. 2006. PMID: 17623896 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,075 results

Search Page

Filters